Rufen

Pneumovax(pneumococcal vaccine polyvalent) was printed in Reader’s Digest (Ventola).” That created a chain effect and shortly later “Boots Pharmaceuticals ran the first DTC broadcast advertisement, which promoted the lower price of its prescription brand of ibuprofen (Rufen), compared with Motrin (Ventola).” Today, the US pharmaceutical industry spends $3.1 billion on advertising prescription drugs directly to consumers. There are proponents of DTC prescription drug ads. They argue that “the ads inform patients about

Business Ethics Second Paper – Deontological Analysis June 19, 2013 Direct-to-Consumer Drug Advertising: Ethical or Not? The United States and New Zealand are the only developed countries that allow direct-to-consumer advertising. Whether the practice of direct to consumer advertising is beneficial to the consumers or not is a highly debated subject with both positions presenting sound reasoning for their position. Whether the practice is beneficial or not to the consumer is not

Healthcare has long been considered as the domain of the medical profession community and now a revolution of different sorts has taken place in the medical field over the last two decades. As consumers have taken a more proactive role in their own healthcare by searching for a lot of health information online, shopping for physicians, seeking second opinions, self-medicating through over-the counter medications and health food supplements, and inquiring about or pushing physicians to prescribe certain

Over the past, several decades direct to consumer pharmaceutical advertising (DTCPA) has rapidly grown. DTCPA is now the most common type of health communication that the public faces. Drug advertising is regulated by the FDA, but it is argued that FDA regulations are too relaxed and not always enforced. Limited research has been conducted on DTCPA, the research that does exist shows that DTCPA is both valuable and harmful to public health. The arguments on both sides of the DTCPA debate are fairly

In 1983, the first television drug advertisement was aired. The drug was Rufen, a pain reliever similar to ibuprofen. Not even 48 hours later, the government had requested the commercial be taken off the air on counts of misinformation. In 2007, congress ruled that these advertisements encouraged unnecessary usage of these drugs (Scott). The government, alongside the American Medical Association, wanted to ban these advertisements permanently, but they could not because the pharmaceutical companies

Direct-to-consumer (DTC) marketing of pharmaceuticals has grown increasingly in the past decade. The American public views prescription drug advertising for a wide range of medical conditions, including high cholesterol, depression, allergies, and erectile dysfunction. The Federal Food and Drug Administration (FDA) regulates the content of these advertisements. Critics also have taken the position that the advertisements garner unearned trust from the public, are misleading, and promote unnecessary